VivoSim Labs (VIVS) filed a DEF 14A for its virtual 2025 Annual Meeting on December 16, 2025, where 2.6 million shares outstanding as of October 17, 2025, will vote. Key proposals include re-electing Class II Directors Cohen and Gobel and ratifying Rosenberg Rich Baker Berman P.A. as auditors; audit fees increased to \(260k for FY2026 from \)175k in FY2024. The board recommends FOR Say-on-Pay and a ONE YEAR frequency.
The company reported substantial Net Losses, including a $2.5M loss for FY2025. Total Shareholder Return (TSR) has declined significantly, dropping from 22.72x in FY2023 to 1.94x
...